1931 — IVD Medical Holding Income Statement
0.000.00%
- HK$8.99bn
- HK$10.40bn
- CNY3.16bn
- 48
- 20
- 55
- 33
Annual income statement for IVD Medical Holding, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 2,428 | 2,731 | 2,749 | 3,088 | 3,162 |
| Cost of Revenue | |||||
| Gross Profit | 476 | 566 | 608 | 672 | 751 |
| Selling / General / Administrative Expenses | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 2,178 | 2,464 | 2,423 | 2,686 | 2,695 |
| Operating Profit | 250 | 267 | 326 | 403 | 468 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 232 | 268 | 284 | 339 | 402 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 155 | 162 | 196 | 237 | 266 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 159 | 175 | 210 | 238 | 260 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 159 | 175 | 210 | 238 | 260 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.119 | 0.137 | 0.165 | 0.177 | 0.174 |
| Dividends per Share |